Henan authorities “exposed themselves” 88.5 million people infected with COVID-nearly 90% from the whole province
Henan officials “unfold themselves” – BBC reported on 9 Jan. Mr. Gan Guancheng management staff of Henan Province central part of china Nearly 90 percent of the province’s population, regarding 88.5 million people, are already infected with COVID-19, but did not specify exactly when the infection occurred.
However, the Zero COVID policy, which keeps the infection rate as low as possible, went into effect in early December 2022. Therefore, many people expected that a major outbreak in Henan Province would happen in the past few weeks.
ภาพประกอบ: A nurse shows the drugs to a family members as elderly patients with COVID symptoms receive intravenous drips while using a ventilators at the emergency ward of a hospital in Fuyang in central China’s Anhui province on Jan. 4, 2023. China’s healthcare authorities declined to include Pfizer’s COVID-treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. (Chinatopix Via AP)
Mr. Gan also said that he traveled to check the situation at a clinic treating patients with severe fever, which had the highest number of infected people on Dec. 19, then the numbers gradually. continued to decline
The Henan official’s revelations conflicted with centralized data from the National Health Commission that said Since relaxing the policy of COVID to zero China has regarding 120,000 new COVID-19 cases out of a population of more than 1.4 billion, and regarding 30 deaths.
While local authorities in many areas across China gradually disclose information regarding COVID-19 infections. That’s different from federal data as well. The city of Qingdao, in Shandong province, said more than 500,000 people were infected with COVID-19 a day, but the central government removed the data and said it received a few dozen new cases each day.
ภาพประกอบ: Family members look following their elderly relatives with COVID symptoms at the emergency ward of a hospital in Fuyang in central China’s Anhui province on Jan. 4, 2023. China’s healthcare authorities declined to include Pfizer’s COVID-treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. (Chinatopix Via AP)
Passengers push their luggage through the international arrivals hall at Beijing Capital International Airport following China lifted the coronavirus disease (COVID-19) quarantine requirement for inbound travellers in Beijing, China January 8, 2023. REUTERS/Thomas Peter
Related news: